Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer

Prostate Cancer and Prostatic Diseases volume 13, pages 117–125 (2010)Cite this article

Subjects

Abstract

Our previous work identified a chromosomal translocation t(4;6) in prostate cancer cell lines and primary tumors. Using probes located on 4q22 and 6q15, the breakpoints identified in LNCaP cells, we performed fluorescence in situ hybridization analysis to detect this translocation in a large series of clinical localized prostate cancer samples treated conservatively. We found that t(4;6)(q22;q15) occurred in 78 of 667 cases (11.7%). The t(4;6)(q22;q15) was not independently associated with patient outcome. However, it occurs more frequently in high clinical T stage, high tumor volume specimens and in those with high baseline PSA (P=0.001, 0.001 and 0.01, respectively). The t(4;6)(q22;q15) occurred more frequently in samples with two or more TMPRSS2:ERG fusion genes caused by internal deletion than in samples without these genomic alterations, but this correlation is not statistically significant (P=0.0628). The potential role of this translocation in the development of human prostate cancer is discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Article 23 September 2019

Nadia Harbeck, Frédérique Penault-Llorca, … Fatima Cardoso

References

  1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10–30.

    Article  PubMed  Google Scholar 

  2. Cuzick J, Fisher G, Kattan MW, Berney D, Oliver T, Foster CS et al. Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer 2006; 95: 1186–1194.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ulbright TM . Male genital tract. In: Alison MR (ed). The Cancer Handbook, vol. 2. Nature Publishing Group: London, 2002, pp 665–687.

    Google Scholar 

  4. Foster CS, Bostwick DG, Bonkhoff H, Damber JE, van der Kwast T, Montironi R et al. Cellular and molecular pathology of prostate cancer precursors. Scand J Urol Nephrol Suppl 2000; 205: 19–43.

    Article  Google Scholar 

  5. Foster CS, Cooper CS . The urgent need to develop independent biomarkers for functional, diagnostic and prognostic application in the field of oncology research. Biomark Med 2009; 3: 329–333.

    Article  PubMed  Google Scholar 

  6. Mitelman F, Johansson B, Mertens F . The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007; 7: 233–245.

    Article  CAS  PubMed  Google Scholar 

  7. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310: 644–648.

    Article  CAS  PubMed  Google Scholar 

  8. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007; 448: 595–599.

    Article  CAS  PubMed  Google Scholar 

  9. Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S et al. Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. Cancer Res 2008; 68: 4971–4976.

    Article  CAS  PubMed  Google Scholar 

  10. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561–566.

    Article  CAS  PubMed  Google Scholar 

  11. Demichelis F, Fall K, Perner S, Andren O, Schmidt F, Setlur SR et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 2007; 26: 4596–4599.

    Article  CAS  PubMed  Google Scholar 

  12. Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 2008; 27: 253–263.

    Article  CAS  PubMed  Google Scholar 

  13. Gopalan A, Leversha MA, Satagopan JM, Zhou Q, Al-Ahmadie HA, Fine SW et al. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res 2009; 69: 1400–1406.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X et al. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009; 458: 97–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lane TM, Strefford JC, Yanez-Munoz RJ, Purkis P, Forsythe E, Nia T et al. Identification of a recurrent t(4;6) chromosomal translocation in prostate cancer. J Urol 2007; 177: 1907–1912.

    Article  CAS  PubMed  Google Scholar 

  16. Lambros MB, Simpson PT, Jones C, Natrajan R, Westbury C, Steele D et al. Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest 2006; 86: 398–408.

    Article  CAS  PubMed  Google Scholar 

  17. Cox D, Oakes D . Analysis of Survival Data. Chapman & Hall: London, New York, 1984.

    Google Scholar 

  18. Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 2006; 8: 141–151.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Liu X, Adams AL . Mucoepidermoid carcinoma of the bronchus: a review. Arch Pathol Lab Med 2007; 131: 1400–1404.

    PubMed  Google Scholar 

  20. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002; 2: 367–376.

    Article  CAS  PubMed  Google Scholar 

  21. Fernandez TV, Garcia-Gonzalez IJ, Mason CE, Hernandez-Zaragoza G, Ledezma-Rodriguez VC, Anguiano-Alvarez VM et al. Molecular characterization of a patient with 3p deletion syndrome and a review of the literature. Am J Med Genet A 2008; 146A: 2746–2752.

    Article  PubMed  Google Scholar 

  22. Belloni E, Trubia M, Mancini M, Derme V, Nanni M, Lahortiga I et al. A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukemia. Genes Chromosomes Cancer 2004; 41: 272–277.

    Article  CAS  PubMed  Google Scholar 

  23. Berger R, Busson M, Baranger L, Helias C, Lessard M, Dastugue N et al. Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements. Leukemia 2006; 20: 319–321.

    Article  CAS  PubMed  Google Scholar 

  24. Karenko L, Hahtola S, Paivinen S, Karhu R, Syrja S, Kahkonen M et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res 2005; 65: 8101–8110.

    Article  CAS  PubMed  Google Scholar 

  25. Panagopoulos I, Strombeck B, Isaksson M, Heldrup J, Olofsson T, Johansson B . Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre-B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement. Br J Haematol 2006; 133: 270–275.

    Article  CAS  PubMed  Google Scholar 

  26. Popovici C, Basset C, Bertucci F, Orsetti B, Adelaide J, Mozziconacci MJ et al. Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene. Genes Chromosomes Cancer 2002; 35: 204–218.

    Article  CAS  PubMed  Google Scholar 

  27. Arakawa H . Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 2004; 4: 978–987.

    Article  CAS  PubMed  Google Scholar 

  28. Furuta J, Nobeyama Y, Umebayashi Y, Otsuka F, Kikuchi K, Ushijima T . Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res 2006; 66: 6080–6086.

    Article  CAS  PubMed  Google Scholar 

  29. Thiebault K, Mazelin L, Pays L, Llambi F, Joly MO, Scoazec JY et al. The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc Natl Acad Sci USA 2003; 100: 4173–4178.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Latil A, Chene L, Cochant-Priollet B, Mangin P, Fournier G, Berthon P et al. Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int J Cancer 2003; 103: 306–315.

    Article  CAS  PubMed  Google Scholar 

  31. Liu W, Chang BL, Cramer S, Koty PP, Li T, Sun J et al. Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers. Clin Cancer Res 2007; 13: 5028–5033.

    Article  CAS  PubMed  Google Scholar 

  32. Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P et al. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res 2007; 67: 8504–8510.

    Article  CAS  PubMed  Google Scholar 

  33. Konishi N, Nakamura M, Kishi M, Ishida E, Shimada K, Matsuyoshi S et al. Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma. Cancer Sci 2003; 94: 764–768.

    Article  CAS  PubMed  Google Scholar 

  34. Mao X, James SY, Yanez-Munoz RJ, Chaplin T, Molloy G, Oliver RT et al. Rapid high-resolution karyotyping with precise identification of chromosome breakpoints. Genes Chromosomes Cancer 2007; 46: 675–683.

    Article  CAS  PubMed  Google Scholar 

  35. Watson SK, Deleeuw RJ, Horsman DE, Squire JA, Lam WL . Cytogenetically balanced translocations are associated with focal copy number alterations. Hum Genet 2007; 120: 795–805.

    Article  PubMed  Google Scholar 

  36. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001; 97: 3581–3588.

    Article  CAS  PubMed  Google Scholar 

  37. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C . Genetic instability and Darwinian selection in tumours. Trends Cell Biol 1999; 9: M57–M60.

    Article  CAS  PubMed  Google Scholar 

  38. Mao X, Young BD, Chaplin T, Shipley J, Lu YJ . Subtle genomic alterations and genomic instability revealed in diploid cancer cell lines. Cancer Lett 2008; 267: 49–54.

    Article  CAS  PubMed  Google Scholar 

  39. De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA et al. Human prostate cancer precursors and pathobiology. Urology 2003; 62 (5 Suppl 1): 55–62.

    Article  PubMed  Google Scholar 

  40. Karan D, Lin MF, Johansson SL, Batra SK . Current status of the molecular genetics of human prostatic adenocarcinomas. Int J Cancer 2003; 103: 285–293.

    Article  CAS  PubMed  Google Scholar 

  41. Joshua AM, Evans A, Van der Kwast T, Zielenska M, Meeker AK, Chinnaiyan A et al. Prostatic preneoplasia and beyond. Biochim Biophys Acta 2008; 1785: 156–181.

    CAS  PubMed  Google Scholar 

  42. Attard G, Jameson C, Moreira J, Flohr P, Parker C, Dearnaley D et al. Hormone-sensitive prostate cancer: a case of ETS gene fusion heterogeneity. J Clin Pathol 2009; 62: 373–376.

    Article  CAS  PubMed  Google Scholar 

  43. Clark J, Attard G, Jhavar S, Flohr P, Reid A, De-Bono J et al. Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene 2008; 27: 1993–2003.

    Article  CAS  PubMed  Google Scholar 

  44. Mehra R, Han B, Tomlins SA, Wang L, Menon A, Wasco MJ et al. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res 2007; 67: 7991–7995.

    Article  CAS  PubMed  Google Scholar 

  45. Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002; 360: 683–689.

    Article  CAS  PubMed  Google Scholar 

  46. Attard G, Swennenhuis JF, Olmos D, Reid AH, Vickers E, A’Hern R et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 2009; 69: 2912–2918.

    Article  CAS  PubMed  Google Scholar 

  47. Wang J, Cai Y, Ren C, Ittmann M . Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res 2006; 66: 8347–8351.

    Article  CAS  PubMed  Google Scholar 

  48. Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, Setlur S et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 2006; 66: 8337–8341.

    Article  CAS  PubMed  Google Scholar 

  49. Mehra R, Tomlins SA, Shen R, Nadeem O, Wang L, Wei JT et al. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol 2007; 20: 538–544.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Olabisi Onilude, Yongwei Yu and Andrew Clear for technical assistance. This work was funded by Orchid Cancer Appeal, Cancer Research UK, Prostate Research Campaign UK, the NCRI Prostate Cancer Collaborative, The Prostate Cancer Charity, The Rosetree Trust and the Grand Charity of Freemasons.

Author information

Authors and Affiliations

  1. Centre for Molecular Oncology and Imaging, Institute of Cancer, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK

    L Shan, R J Yáñez-Muñoz, S C Kudahetti, J Yang, S Kia, X Mao, B D Young, T D Oliver, D M Berney & Y-J Lu

  2. Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK

    L Ambroisine, G Fisher & J Cuzick

  3. Male Urological Cancer Research Centre, Institute of Cancer Research, Surrey, UK

    J Clark, A Fletcher, P Flohr, S Edwards, G Attard, J De-Bono & C S Cooper

  4. Division of Cellular and Molecular Pathology, University of Liverpool, Liverpool, UK

    C S Foster

  5. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    V Reuter

  6. King's College London, Thames Cancer Registry, London, UK

    H Moller

  7. Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    P Scardino

Authors
  1. L Shan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Ambroisine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R J Yáñez-Muñoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Fisher
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S C Kudahetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S Kia
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. X Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Fletcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. P Flohr
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. S Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. G Attard
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. J De-Bono
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. B D Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. C S Foster
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. V Reuter
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. H Moller
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. T D Oliver
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. D M Berney
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. P Scardino
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. J Cuzick
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. C S Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Y-J Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Transatlantic Prostate Group

Corresponding author

Correspondence to Y-J Lu.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shan, L., Ambroisine, L., Clark, J. et al. The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer. Prostate Cancer Prostatic Dis 13, 117–125 (2010). https://doi.org/10.1038/pcan.2010.2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2010.2

Keywords

This article is cited by

Search

Advanced search

Quick links